METHOD FOR TREATING A DISORDER
#902LEVODOPA DOSING REGIMEN
#903LEVODOPA DOSING REGIMEN
#904 ✅ Patent 12,303,482 granted on 2025-05-20Levodopa dosing regimen
#905LEVODOPA DOSING REGIMEN
#906 ✅ Patent 12,370,163 granted on 2025-07-29LEVODOPA DOSING REGIMEN
#907 ✅ Patent 12,324,796 granted on 2025-06-10SLEEP-IMPROVING COMPOSITIONS AND METHODS OF USE
#908NOVEL ANTIVIRAL COMPOSITIONS COMPRISING OLEIC ACID
#909MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
#910COMPOSITIONS FOR DELIVERY OF LADOSTIGIL
#911METHODS OF PROVIDING SOLRIAMFETOL THERAPY TO SUBJECTS WITH IMPAIRED RENAL FUNCTION
#912METHOD OF TREATING CONDITIONS RELATED TO THE PGI2 RECEPTOR
#913LYMPH-TARGETING FORMULATIONS
#914DOCETAXEL COMPOSITIONS AND METHODS
#915CANCER-CELL PROLIFERATION INHIBITOR AND CANCER-CELL-PROLIFERATION INHIBITION ENHANCER
#916CARBAMOTHIOATE, AND CARBAMODITHIOATE DERIVATIVES OF MDMA, MDA OR ITS OPTICALLY ACTIVE (R)- OR (S)-MDMA AND MDA ISOMERS
#917ORALLY ADMINISTRABLE COMPOSITIONS COMPRISING AVOCADO/SOYBEAN UNSAPONIFIABLES AND LIPOIC ACID AND METHODS OF ADMINISTRATION
#918Pharmaceutical Composition for Preventing or Treating Triple-Negative Breast Cancer
#919ETRASIMOD FOR USE IN TREATING S1P1 RECEPTOR-ASSOCIATED DISORDERS IN COMBINATION WITH HORMONE TREATMENT
#920METHODS FOR TREATING SUBJECTS WITH ABDOMINAL OBESITY HYPERTRIGLYCERIDEMIA AND/OR IMPAIRED GLUCOSE
#921STABLE PHARMACEUTICAL COMPOSITIONS OF CLONIDINE
#922METHODS FOR TREATING MYC-AMPLIFIED CANCER
#923HDAC INHIBITOR OKI-179 IN COMBINATION WITH BINIMETINIB FOR THE TREATMENT OF CANCER
#924METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS WITH RAPAMYCIN IN A STABLE, SUPER-SATURATED STATE
#925Compositions to Enhance and Extend Quality of Life
#926BIOMARKERS FOR NANOPARTICLE COMPOSITIONS
#927PROPYLENE KETONE-CONTAINING BIOINHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF
#928EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD) AND OF LSD ANALOGS TO ASSIST PSYCHOTHERAPY FOR GENERALIZED ANXIETY DISORDER OR OTHER ANXIETY NOT RELATED TO LIFE-THREATENING ILLNESS
#929USE OF AMINOPYRIDINE, IN PARTICULAR AMIFAMPRIDINE, FOR THE TREATMENT OF A VIRALLY-ASSOCIATED FATIGUE
#930COMPOUNDS FOR USE IN THE TREATMENT OF DYSTROPHINOPATHIES
#931METHODS OF TREATING COMPLEX REGIONAL PAIN SYNDROME
#932TREATMENT OF CELL PROLIFERATION-ASSOCIATED CONDITIONS USING A COMBINATION OF A CLB-B INHIBITOR AND AN ADDITIONAL THERAPEUTIC AGENT
#933Uses of Selonsertib in the Preparation of Drugs for the Treatment of Cancer
#934PHARMACEUTICAL COMPOSITION OF ANTIPLATELET DRUG, AND USE THEREOF
#935NICOTINE FORMULATION
#936ORAL COMPOSITIONS WITH REDUCED WATER CONTENT
#937EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF
#938METHODS FOR TREATING IMMUNODEFICIENCY DISEASE
#939INJECTABLE FORMULATION COMPRISING ISOXAZOLINE DERIVATIVE AND METHOD FOR PREPARING SAME
#940Pharmaceutical Composition of Ethidium Bromide and Use in Treating Cancer
#941Stabilizing Camptothecin Pharmaceutical Compositions
#942Diketopiperazine Microparticles with Defined Specific Surface Areas
#943METHODS FOR TREATING IMMUNE DISEASES
#944METHODS OF TREATING NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY USING MODIFIED FORMS OF TRIMETAZIDINE
#945COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR
#946AMILORIDE FOR USE IN THE TOPICAL TREATMENT OF SOMATOSENSORY IMPAIRMENTS
#947NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF
#948PHARMACEUTICAL COMPOUND
#949PHARMACEUTICAL COMPOSITION FOR RELIEVING OR TREATING PAIN BY REGULATING CEREBELLAR GLIAL CELLS AND METHOD FOR RELIEVING OR TREATING PAIN
#950PLATINUM-RESISTANT CANCER TREATMENT
#951HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS
#952THERAPEUTIC OR PREVENTIVE AGENT FOR EYE DISEASES
#953NURR1:RXR ACTIVATING COMPOUNDS FOR SIMULTANEOUS TREATMENT OF SYMPTOMS AND PATHOLOGY OF PARKINSON'S DISEASE
#954TREATMENT OF HEMATOLOGICAL MALIGNANCIES WITH MENIN INHIBITORS AND P-GLYCOPROTEIN INHIBITORS
#955PHARMACEUTICAL COMPOSITION COMPRISING ALLOPURINOL, FEBUXOSTAT OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR PREVENTION OR TREATMENT OF CHRONIC KIDNEY DISEASE IN SUBJECT HAVING HIGH SERUM URIC ACID CONCENTRATION
#956p38 MAPK INHIBITORS AND USES THEREOF
#957ORAL SOLID TABLET COMPRISING BRUTON'S TYROSINE KINASE INHIBITOR AND PREPARATION METHOD THEREFOR
#958MEDICATION TO ALLEVIATE NAUSEA WITH OR WITHOUT VOMITING, VERTIGO, AND PAIN
#959METHOD OF TREATING PAIN OR INTERSTITIAL CYSTITIS USING INDOLE COMPOUND
#960LINEZOLID FORMULATIONS
#961METHOD FOR TREATING CANCER
#962ANTI-CORONAVIRUS EFFECT AND APPLICATION OF P14K INHIBITOR
#963BROMODOMAIN INHIBITORS
#964Compositions and Methods for the Treatment of Sexual Dysfunctions
#965MODULATION OF AVERSIVE AND SALT TASTES
#966NEFOPAM DOSAGE FORMS AND METHODS OF TREATMENT
#967CONTRACEPTIVE METHODS WITH SCHEDULED BLEEDING EFFECTS
#968METHOD AND DRUG FOR TREATING NEURONAL CEROID LIPOFUSCINOSIS
#969INDUCTION OF IRREVERSIBLE INFERTILITY IN FEMALE MAMMALIAN ANIMALS USING A SINGLE PROGESTERONE IMPLANT
#970COMPOSITIONS FOR VITAMIN D PRODUCTION
#971CONTRACEPTIVE METHODS WITH IMPROVED PEARL INDEX
#972SALICYLIC ACID COMPOSITIONS AND USES THEREOF
#973IMIDAZOLATE GOLD COMPOUNDS FOR THE TREATMENT OF LUNG CANCER
#974IMMUNOMODULATORY LIPIDS AND USES THEREOF
#975POLYPEPTIDE COUPLED BORON CARRYING AGENT, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL FORMULATION
#976COMPOSITIONS AND METHODS FOR COVID-19 TREATMENT
#977Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections
#978GEMCITABINE LIPOSOME PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF
#979COMPOSITIONS FOR AND METHODS OF TREATING, PREVENTING, AND/OR MITIGATING PAIN
#980PHARMACEUTICAL COMPOSITION CONTAINING STIMULANT FOR PWAR5 EXPRESSION AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING INFECTIOUS DISEASES DUE TO HEPATITIS C VIRUS
#981ANTIVIRAL SULFATED CHITOSAN DERIVATIVES
#982POLYIMIDAZOLIUM-BASED CATIONIC ANTIMICROBIAL POLYMERS FOR NOVEL MASTITIS PROPHYLACTIC SOLUTIONS
#983PROPHYLAXIS AND THERAPY FOR OCULAR DISEASES LEADING TO BLINDNESS
#984A NON-SWALLOWED, ANTACID CHEWING GUM PRODUCT, A PROCESS FOR ITS PREPARATION AND USES THEREOF
#985ALUMINUM-MANGANESE COMPOSITE NANOCRYSTAL, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#986Compositions and kits for use in wound healing, tissue regeneration and/or bone regeneration
#987COMPOSITIONS AND METHODS OF TREATMENT FOR CANCERS
#988CELLS AND METHODS
#989CONSTRUCTION AND APPLICATION OF ENHANCED NEUTROPHIL DRUG
#990COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE CELL FUNCTION USING MODIFIED CELLS WITH GLYCOCALYX EDITING ENZYMES
#991TCR TARGETING CYTOMEGALOVIRUS ANTIGEN, T CELL EXPRESSING TCR, AND APPLICATION
#992COMPOSITIONS INCLUDING KILLER INNATE-LIKE T CELLS AND USES THEREOF
#993METHODS FOR THE PRODUCTION OF TCR GAMMA DELTA + T CELLS
#994SYNNOTCH RECEPTOR AND USE THEREOF
#995RENAL CELL POPULATIONS AND USES THEREOF
#996CELLS HAVING IMPROVED PROLIFERATIVE CAPACITY AND REDUCED CELLULAR SENESCENCE
#997METHOD FOR ENHANCING EXPRESSION OF INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IN UMBILICAL CORD MESENCHYMAL STEM CELL AND METHOD FOR OBTAINING MULTIPOTENT UMBILICAL CORD MESENCHYMAL STEM CELL
#998BONE AUGMENTATION UTILIZING MUSCLE-DERIVED PROGENITOR COMPOSITIONS, AND TREATMENTS THEREOF
#999CARDIAC STEM CELLS FOR CARDIAC REPAIR
#1000AKKERMANSIA FOR PREVENTING AND/OR TREATING REWARD DYSREGULATION DISORDERS
#1001AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE GASTROINTESTINAL SYSTEM
#1002OVARIAN CARE FORMULA CONTAINING A-SDGPLUS AND PREPARATION METHOD THEREFOR
#1003MICROORGANISMS WITH REDUCED COMPETENCE
#1004LACTOBACILLUS PARACASEI NB23 STRAIN AND METHOD OF USING THE SAME TO INCREASE MUSCLE MASS AND TO PREVENT/TREAT METABOLIC SYNDROME
#1005NASAL ANTI-CANCER THERAPIES
#1006COMBINATIONS OF CHECKPOINT INHIBITORS AND ONCOLYTIC VIRUS FOR TREATING CANCER
#1007RECOMBINANT ONCOLYTIC VIRUS AND USE THEREOF
#1008SINGLE CELL PROTEIN PRODUCTS
#1009SOLVENTS, METHODS, AND SYSTEMS FOR ISOLATING CANNABINOIDS FROM PLANTS EXTRACTS OR FROM SYNTHETIC PATHWAYS
#1010FORMULATIONS AND METHODS FOR SKIN CARE
#1011SYSTEM AND METHOD OF PROCESSING HEMP FOR EXTRACTION OF SELECT COMPONENTS THEREOF
#1012PHARMACEUTICAL COMPOSITION FOR USE IN INCREASING HAIR, MODIFYING SCALP OR SKIN, HEALING A WOUND, PROMOTING OSTEOGENESIS, OR MODIFYING HAIR
#1013COMPOSITIONS FOR TREATING SEA LICE IN SALMON AND RELATED METHODS
#1014COMPOSITIONS AND METHODS FOR EXTRACTING COMPOUNDS
#1015PHARMACEUTICAL COMPOSITION, PHYTOMEDICINE, KIT, PROCESS FOR PREPARING A PHARMACEUTICAL COMPOSITION, AND, USES OF ESSENTIAL OIL AND/OR A PHARMACEUTICAL COMPOSITION
#1016ASHWAGANDHA EXTRACTS AND FORMULATIONS THEREOF
#1017COMBINATION, COMPOSITION, AND METHOD OF ADMINISTERING THE COMBINATION OR COMPOSITION TO ANIMALS
#1018EDIBLE PLANT-DERIVED NANOPARTICLES FOR REGULATION OF GUT MICROBIOTA
#1019INHIBITION OF TREM RECEPTOR SIGNALING WITH PEPTIDE VARIANTS
#1020COMPOSITION FOR PROMOTING HAIR GROWTH, PHARMACEUTICAL COMPOSITION FOR PROMOTING HAIR GROWTH COMPRISING THE COMPOSITION, AND METHOD FOR PROMOTING HAIR GROWTH BY USING THE SAME
#1021CYCLIC PEPTIDE FOR TRAPPING INTERLEUKIN-1 BETA
#1022METHOD FOR PREVENTING OR TREATING PARKINSON'S DISEASE
#1023SCO-spondin-derived polypeptides for treating biological barriers dysfunction
#1024NOVEL COMBINATION TREATMENT REGIMEN OF BACTERIAL INFECTIONS
#1025METHODS OF TREATING A CYTOKINE STORM RELATED DISEASE WITH RECOMBINANT MUTATED HUMAN ANGIOPOIETIN-LIKE 4
#1026COMPOSITION FOR PREVENTION OR TREATMENT OF DRY EYE DISEASE COMPRISING HAPLN1
#1027COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS
#1028Mutant Peptides And Methods Of Treating Subjects Using The Same
#1029COMPLEXES FOR TREATING SENSITIVITY
#1030SAP FC FUSION PROTEINS AND METHODS OF USE
#1031PROTEIN FOR TREATMENT OF INFLAMMATORY DISEASES
#1032Use of a VEGF Antagonist to Treat Angiogenic Eye Disorders
#1033METHOD FOR ALLEVIATING PULMONARY FIBROSIS USING EPIDERMAL GROWTH FACTOR
#1034MEDICAL COMPOSITION FOR TREATING PATIENTS EXHIBITING CARDIAC DECOMPENSATION
#1035SEMAGLUTIDE FOR USE IN MEDICINE
#1036PHARMACEUTICAL FORMULATIONS
#1037ORAL OCTREOTIDE FOR TREATMENT OF DISEASE
#1038I-TYPE RECOMBINANT COLLAGEN WITH HIGH TRANSDERMAL ABSORBABILITY, AND USE THEREOF
#1039METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#1040TREATMENT OF LIVER CANCERS BY DISRUPTING THE BETA-CATENIN/TCF-4 BINDING SITE LOCATED UPSTREATM OF MEG3 IN THE DLK1/DIO3 LOCUS
#1041PROTEOLYTIC ENZYME COMPOSITION
#1042DYSTROPHIN GENE EXON DELETION USING ENGINEERED NUCLEASES
#1043COMPOSITIONS COMPRISING GLUCOCEREBROCIDASE AND METHODS OF USE THEREOF
#1044NANODISC COMPRISING ANGIOTENSIN CONVERTING ENZYME 2
#1045LIQUID BOTULINUM TOXIN FORMULATION AND USE THEREOF
#1046PROCESSES FOR PRODUCING COMPOSITIONS WITH IMPROVED SAFETY PROFILE HAVING LIPASE ACTIVITY AND COMPOSITIONS SUITABLE FOR PHARMACEUTICAL USE
#1047Anti-Alpha-Synuclein Therapeutic Vaccines
#1048METHOD OF MAKING A PERSONALIZED CANCER VACCINE
#1049IL-15-BASED FUSIONS TO IL-12 AND IL-18
#1050CONSENSUS SEQUENCE OF THE ANTIGEN TELOMERASE AND THE USE THEREOF IN PREVENTIVE AND THERAPEUTIC VACCINATION
#1051A Conjugate
#1052VACCINE AGAINST LEPTOSPIROSIS
#1053NOVEL LIVE MULTI-ANTIGENIC RECOMBINANT VACCINE AGAINST TUBERCULOSIS
#1054IMMUNOGENIC COMPOSITION FOR PARATUBERCULOSIS
#1055IMMUNOGENS TARGETING ANTHRAX
#1056Neisseria Meningitidis Vaccine
#1057METHODS AND COMPOSITIONS FOR MULTIVALENT VACCINES
#1058AFRICAN SWINE FEVER VACCINE COMPOSITION
#1059METHODS AND COMPOSITIONS FOR VACCINATION AGAINST HETEROSUBTYPIC INFLUENZA VIRUSES USING AN ADENOVIRAL VECTOR LEADING TO ENHANCED T CELL RESPONSE THROUGH AUTOPHAGY
#1060AUTOLOGOUS CELL BASED SARS-COV-2 VACCINES
#1061DNA ADJUVANT HYDROGEL-BASED PEPTIDE VACCINE, AND PREPARATION METHOD AND USE THEREOF
#1062CORONAVIRUS VACCINE
#1063ALUMINUM NANOCRYSTAL DELIVERY SYSTEM, AND SELF-ASSEMBLED PARTICLE ADJUVANT VACCINE BASED ON BINDING OF ALUMINUM NANOCRYSTAL DELIVERY SYSTEM AND VACCINE ANTIGEN MOLECULE
#1064NKT CELL LIGAND-CONTAINING LIPOSOME COMPOSITION
#1065EPICHAPEROME INHIBITION TO IMPROVE T CELL RESPONSES
#1066COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS
#1067FCRN ANTAGONISTS WITH IMPROVED HALF-LIFE AND METHODS OF USE
#1068COMBINATION THERAPY COMPRISING AN ANTI-IL-23 ANTIBODY AND A CORTICOSTEROID FOR TREATING PSORIASIS
#1069COMPOSITIONS FOR ORAL DELIVERY OF BIOTHERAPEUTICS
#1070CD70 COMBINATION THERAPY
#1071COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANTIBODY AND AN ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY
#1072CD3-TARGETED LENTIVIRAL VECTORS AND USES THEREOF
#1073MODIFIED PRIMARY IMMUNE CELLS FOR INDUCTION OR ENHANCEMENT OF IMMUNOTHERAPY
#1074COMPOSITIONS AND METHODS FOR MODULATING THE IMMUNE SYSTEM
#1075METHODS FOR ISOLATING, CULTURING, AND GENETICALLY ENGINEERING IMMUNE CELL POPULATIONS FOR ADOPTIVE THERAPY
#1076MULTICHAIN ANTIGEN-SPECIFIC RECEPTORS FOR CELL-BASED IMMUNOTHERAPY
#1077MIGRATORY MODIFIED DIFFERENTIATED B CELLS FOR CANCER THERAPY
#1078COMPOSITIONS COMPRISING NKG2D, CXCR2, AND DAP10/DAP12 FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#1079IMPROVED PRIMARY HUMAN NK CELL EXPANSION AND FUNCTION BY CHIMERIC CYTOKINE RECEPTOR
#1080BINDING PROTEINS AND ENGINEERED CELLS SPECIFIC FOR NEOANTIGENS AND USES THEREOF
#1081NUCLEIC ACID DELIVERY MATERIAL
#1082FUSED IMIDE DERIVATIVE
#1083NEW CARBOHYDRATE DERIVATIVES AS MIMETICS OF BLOOD GROUP A AND B ANTIGENS
#1084PHARMACEUTICAL COMPOSITION CONTAINING PEGYLATED EXENATIDE VARIANT AND USE THEREOF
#1085DRUG CONJUGATE OF GLUCOCORTICOID
#1086ANTIBODY-DRUG CONJUGATES INVOLVING ERIANIN AND THE FABRICATION METHODS AND APPLICATIONS THEREOF
#1087ANTIBODY CONJUGATES SPECIFIC FOR MUCIN-1 AND METHODS OF USE THEREOF
#1088COMBINATION THERAPY WITH AN ANTI-AXL ANTIBODY-PBD CONJUGATE AND NANOCUPS
#1089NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF
#1090MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES
#1091Method And Molecules
#1092IMMUNOTHERAPY FOR CANCER
#1093ANTI-TM4SF1 ANTIBODY-DRUG CONJUGATES COMPRISING CLEAVABLE LINKERS AND METHODS OF USING SAME
#1094ANTI-TROP2 ANTIBODY COMBINATION THERAPIES AND METHODS OF USE THEREOF
#1095ANTIBODY-BOUND LIPID NANOPARTICLE COMPRISING ANTIBODY BOUND TO MEMBRANE SCAFFOLD PROTEIN
#1096ANTIBIOTIC AMPHIPHILIC NANOPARTICLE AND METHODS OF USING THE SAME AGAINST GRAM-NEGATIVE AND/OR GRAM-POSITIVE BACTERIA
#1097USES AND FORMULATIONS OF CAMPTOTHECIN (CPT)-CONTAINING NANOPARTICLES
#1098Lipid Nanoparticle Compositions and Methods for mRNA Delivery
#1099IMMUNE SYSTEM MODULATORS AND USES THEREOF
#1100LIPID NANOPARTICLES COMPRISING VENEZUELAN EQUINE ENCEPHALITIS (VEE) REPLICON AND USES THEREOF
#1101GPR17 PROMOTER-BASED TARGETING AND TRANSDUCTION OF GLIAL PROGENITOR CELLS
#1102COMPOSITION AND METHODS FOR TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY
#1103MATERIALS AND METHODS FOR THE TREATMENT OF LIMB GIRDLE MUSCULAR DYSTROPHY
#1104NUCLEIC ACID CONSTRUCTS ENCODING A CELL PENETRATING PEPTIDE, SIGNAL SEQUENCE AND TRANSCRIPTION FACTOR EB AND USES THEREOF
#1105COMPOSITIONS AND METHODS FOR NEUROLOGICAL DISEASES
#1106SYNPOPTOSIS CIRCUITS FOR PROGRAMMABLE CELL DEATH CONTROL
#1107METHODS OF TREATING NEURODEGENERATIVE DISORDERS
#1108NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL FOR INCREASING THE EXPRESSION OF AN ENCODED PROTEIN
#1109BASE EDITING OF ANGPTL3 AND METHODS OF USING SAME FOR TREATMENT OF DISEASE
#1110METHODS OF TREATING GAUCHER DISEASE AND GBA-PARKINSON’S DISEASE
#1111HYDRODYNAMIC GENE DELIVERY
#1112ASSESSMENT OF ADVERSE EVENTS INDUCED BY ADMINISTRATION OF ANTITUMOR DRUG AND/OR IMMUNE CHECKPOINT INHIBITOR BY USING DISEASE MODEL MOUSE
#1113CYANINE DYE NANOPARTICLES FOR SENESCENCE IMAGING
#1114RED-SHIFTED FLUOROPHORES AND METHODS OF USING THE SAME
#1115NEAR-INFRARED FLUORESCENT QUANTUM DOT FOR ACHIEVING RAPID RENAL CLEARANCE, AND PREPARATION METHOD AND APPLICATION THEREOF
#1116FORMULATION OF CONTRAST MEDIA AND PROCESS OF PREPARATION THEREOF
#1117MICROBUBBLE LYOPHILIZED PREPARATION FOR ULTRASONIC RADIOGRAPHY, CONTRAST AGENT, AND PREPARATION METHOD
#1118SYSTEMS AND METHODS OF GENERATING LIPID, PROTEIN, AND/OR PROTEIN SHELLED BUBBLES
#1119SURFACE MODIFICATION OF MICRO-BUBBLES AND NANOPARTICLES BASED ON POLY(ALKYLCYANOACRYLATE)
#1120Radiopharmaceutical Compositions of Radioactive Halogenated Benzylguandine
#1121PROBE FOR NUCLEAR MEDICAL TESTING
#1122SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST MET
#1123RADIOACTIVE COMPLEX OF ANTI-VEGF ANTIBODY, AND RADIOPHARMACEUTICAL
#1124MULTIFUNCTIONAL ULTRASONIC CLEANING DEVICE
#1125INTERMITTENT CATHETER STORAGE/STERILIZATION/WARMING
#1126INTERMITTENT CATHETER STORAGE/STERILISATION
#1127INTERMITTENT CATHETER STORAGE/STERILISATION
#1128DEVICE AND METHOD FOR THE GENERATION, CONTROL, AND APPLICATION OF HYDROGEN PEROXIDE VAPOR DOSE
#1129CONTROL ENGINE, SYSTEM AND METHOD FOR CONTROLLING ONE OR MORE UV-C LIGHT SOURCES
#1130CONTAINER FOR SANITIZING APPLICATIONS CONFIGURED TO SECURE A pH SENSITIVE COLOR INDICATOR
#1131SCENT CONTROL ACCORDING TO LOCAL CONDITIONS OF A SCENT CONTROL DEVICE
#1132AROMA PROVIDING DEVICE
#1133GRAVITY-FED VOLATILE LIQUID AIR FRESHENING SYSTEMS
#1134ABSORBENT ANTIMICROBIAL WOUND DRESSINGS
#1135PHOTOPOLYMERISABLE COMPOSITION FOR ADHESIVE FOR BIOLOGICAL TISSUES
#1136COSMETIC PRODUCT CONTAINING STERILE PCL MICROSPHERES
#1137COMPRESSED IMPLANTS FOR SOFT TISSUE REPAIR
#1138PORT-ACCESSIBLE MULTIDIRECTIONAL REINFORCED MINIMALLY INVASIVE COLLAGEN DEVICE FOR SOFT TISSUE REPAIR
#1139CFR-PEEK ORTHOPEDIC IMPLANT AND PREPARATION METHOD THEREFOR, AND WIRELESS SENSING DEVICE
#1140DECELLULARIZED MUSCLE MATRICES AND METHODS FOR MAKING AND USING SAME
#1141NERVE GRAFTS AND METHODS OF PREPARATION THEREOF
#1142NERVE GRAFTS AND METHODS OF PREPARATION THEREOF
#1143METHOD FOR PREPARING BIOLOGICAL VALVE MATERIAL BY MEANS OF DOUBLE-BOND POLYMERIZATION AFTER ALDEHYDE CROSSLINKING, AS WELL AS BIOLOGICAL VALVE MATERIAL AND USE
#1144TISSUE ENGINEERING AND DRUG DELIVERY DEVICE
#1145DISPOSABLE SYSTEM AND METHOD FOR PREPARING A COMPRESSED HYDROGEL
#1146INTERMITTENT URINARY CATHETER HAVING MULTIPLE DRAINAGE OPENINGS
#1147Fluoropolymer Based Anti-Thrombotic Coatings
#1148OSTEOSYNTHESIS SYSTEM WITH BONE PLATE AND BONE ANCHOR MADE OF MAGNESIUM ALLOYS
#1149HIGHLY CONDUCTIVE TISSUE-LIKE HYDROGEL ADHESIVE FOR BIOELECTRONICS AND MANUFACTURING THEREOF
#1150MEDICAL DEVICES COATED WITH SHAPE MEMORY POLYMER FOAMS
#1151Bone Marrow Adipose Portion Isolation Methods
#1152SCREEN EXCHANGE DEVICE, BIOLOGICAL TISSUE SIZE REDUCTION SYSTEM COMPRISING SAME, BIOLOGICAL TISSUE SIZE REDUCTION METHOD USING SAME, AND METHOD FOR SEPARATING TARGET SUBSTANCE FROM RELEVANT BIOLOGICAL TISSUE
#1153INDEPENDENTLY-CONTROLLED TWO-SIDED BREAST PUMP
#1154Connector and breast pump with the same
#1155DIALYSIS SYSTEM AND METHODS
#1156PHASED CONVECTIVE OPERATION
#1157CONTROL OF A MACHINE FOR PERITONEAL DIALYSIS
#1158APPARATUS FOR EXTRACORPOREAL BLOOD TREATMENT
#1159HEART LUNG MACHINE WITH CONTROL ASSEMBLY
#1160APPARATUS FOR THE EXTRACORPOREAL TREATMENT OF BLOOD
#1161Autonomous Waste Collection Assembly and Medical Waste Collection System and Methods
#1162SENSING CANNULA SYSTEMS
#1163NEGATIVE PRESSURE WOUND THERAPY APPARATUSES AND METHODS FOR USING THE SAME
#1164CANISTER STATUS DETECTION IN WOUND FOR PRESSURE THERAPY SYSTEMS
#1165MEDICAL DEVICES WITH A NEGATIVE PRESSURE SOURCE AND RELATED SYSTEMS AND METHODS OF USE
#1166WOUND DRESSING
#1167SYSTEMS AND METHODS FOR OPERATING NEGATIVE PRESSURE WOUND THERAPY DEVICES
#1168CARTON
#1169RADIOPHARMACEUTICAL DELIVERY SYSTEM FOR PATIENT INFUSION
#1170AUTOMATED INSERTION ASSEMBLY
#1171DEVICE FOR DELIVERING INSULIN WITH BASEPLATE AND INTEGRATED MEMS MICROPUMP AND PRESSURE SENSOR
#1172SYSTEM AND METHOD FOR INSULIN PUMP MEDICAL DEVICE INCLUDING A SLIDER ASSEMBLY WHEREIN IMAGES ON DISPLAY ALLOW FOR HIGHLIGHTING AND MAGNIFYING IMAGES
#1173PATCH-SIZED FLUID DELIVERY SYSTEMS AND METHODS
#1174IMPLANTABLE MEDICAL DEVICES THAT DETECT INADVERTENT DELIVERY OF DRUG TO A SUBCUTANEOUS POCKET
#1175INFUSION PUMP ASSEMBLY
#1176FLUID INJECTOR SYSTEM, METHOD OF PREVENTING FLUID BACKFLOW, AND COMPUTER PROGRAM PRODUCT
#1177DIABETES THERAPY BASED ON DETERMINATION OF FOOD ITEM
#1178PATIENT CARE SYSTEM FOR CRITICAL MEDICATIONS
#1179INTEGRATED INSULIN DELIVERY SYSTEM WITH CONTINUOUS GLUCOSE SENSOR
#1180TIME AVERAGED BASAL RATE OPTIMIZER
#1181AUTO-INJECTOR AND RELATED METHODS OF USE
#1182AUTO-INJECTOR
#1183AUTO-INJECTOR
#1184AUTO-INJECTOR
#1185AUTO-INJECTOR
#1186AUTO-INJECTOR
#1187MEDICAMENT DELIVERY DEVICES FOR ADMINISTRATION OF A MEDICAMENT WITHIN A PREFILLED SYRINGE
#1188Auto-Injector
#1189Auto-Injector
#1190Auto-Injector
#1191 ✅ Patent 12,337,148 granted on 2025-06-24Auto-Injector
#1192SUB-ASSEMBLY WITH FEEDBACK FOR A MEDICAMENT DELIVERY DEVICE
#1193SMART INJECTION SYSTEM
#1194AUTO INJECTOR WITH ADAPTABLE AIR-SHOT MECHANISM
#1195DEVICES AND METHODS FOR PRECISION DOSE DELIVERY
#1196SYRINGE AND GASKET SYSTEMS
#1197DOSE DETECTION SYSTEM MODULE FOR A MEDICATION DELIVERY DEVICE
#1198DOSE DELIVERY DEVICE WITH MODIFIED DECOUPLING CLUTCH
#1199A sub-assembly for a medicament delivery device
#1200Drug Delivery Device